Want to see IPHA full AI Analyst Report?
Innate Pharma (IPHA) Q4 2021 Earnings Report
IPHA Q4 2021 EPS Results
- Actual EPS
- -$0.38
- Consensus EPS
- -$0.19
- Beat/Miss
- Missed by -$0.19
- One Year Ago EPS
- -$0.81
IPHA Q4 2021 Revenue Results
- Actual Revenue
- $3.24M
- Expected Revenue
- $26.08M
- Beat/Miss
- Missed by -$22.84M
- YoY Revenue Growth
- -89.83%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/24/2022
- Time
- Before Open
- Conference Call
- Thursday, March 24, 2022
IPHA Upcoming Earnings
Innate Pharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
IPHA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.29- | -0.36 | ― | ― |
| Sep 17, 2026 | 2026 (Q2) | -0.18-0.24 | -0.3 | 18.58% (+0.06) | |
| Mar 26, 2026 | 2025 (Q4) | -0.14-0.36 | -0.35 | -3.47% (-0.01) | |
| Sep 17, 2025 | 2025 (Q2) | -0.33-0.30 | -0.34 | 13.45% (+0.05) | |
| Mar 27, 2025 | 2024 (Q4) | -0.27-0.35 | -0.13 | -166.15% (-0.22) | |
| Sep 12, 2024 | 2024 (Q2) | -0.30-0.34 | 0.02 | -1728.57% (-0.36) | |
| Mar 21, 2024 | 2023 (Q4) | -0.44-0.13 | -0.88 | 85.23% (+0.75) | |
| Sep 14, 2023 | 2023 (Q2) | 0.090.02 | 0.08 | -73.75% (-0.06) | |
| Mar 23, 2023 | 2022 (Q4) | -0.41-0.88 | -0.38 | -132.80% (-0.50) | |
| Sep 15, 2022 | 2022 (Q2) | 0.380.08 | -0.35 | 122.54% (+0.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed